EQS-Adhoc: Relief Therapeutics Comments on Certain Statement

EQS-Adhoc: Relief Therapeutics Comments on Certain Statements Made by NRx Pharmaceuticals in its Registration Statement on Form S-1 Filed on September 3, 2021

EQS-Adhoc: Relief Therapeutics Comments on Certain Statements Made by NRx Pharmaceuticals in its Registration Statement on Form S-1 Filed on September 3, 2021

boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Geneva , Genè , Switzerland , United States , United Kingdom , Swiss , Michael Miller , Jack Weinstein , Advita Lifescience Gmb , Linkedin , Pharma Research , Eqs Group , Swiss Exchange , Nrx Pharmaceuticals Inc , Nrx Pharmaceuticals , Holdings Ag Key , Rx Communications Group , European Union , Group News Service , Neurorx Inc , Therapeutics Comments , Certain Statements Made , Registration Statement , Binding Collaboration Agreement , While Relief , Collaboration Agreement , Vasoactive Intestinal Peptide , License Agreement , Acer Therapeutics , Urea Cycle Disorders , Maple Syrup Urine , Advita Lifescience Gmbh ,